Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Cardiomyopathy | Research

Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset

Authors: Raffaello Ditaranto, Giuseppe Boriani, Mauro Biffi, Massimiliano Lorenzini, Maddalena Graziosi, Matteo Ziacchi, Ferdinando Pasquale, Giovanni Vitale, Alessandra Berardini, Rita Rinaldi, Giovanna Lattanzi, Luciano Potena, Sofia Martin Suarez, Maria Letizia Bacchi Reggiani, Claudio Rapezzi, Elena Biagini

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Objective

To investigate differences in cardiac manifestations of patients affected by laminopathy, according to the presence or absence of neuromuscular involvement at presentation.

Methods

We prospectively analyzed 40 consecutive patients with a diagnosis of laminopathy followed at a single centre between 1998 and 2017. Additionally, reports of clinical evaluations and tests prior to referral at our centre were retrospectively evaluated.

Results

Clinical onset was cardiac in 26 cases and neuromuscular in 14. Patients with neuromuscular presentation experienced first symptoms earlier in life (11 vs 39 years; p <  0.0001) and developed atrial fibrillation/flutter (AF) and required pacemaker implantation at a younger age (28 vs 41 years [p = 0.013] and 30 vs 44 years [p = 0.086] respectively), despite a similar overall prevalence of AF (57% vs 65%; p = 0.735) and atrio-ventricular (A-V) block (50% vs 65%; p = 0.500). Those with a neuromuscular presentation developed a cardiomyopathy less frequently (43% vs 73%; p = 0.089) and had a lower rate of sustained ventricular tachyarrhythmias (7% vs 23%; p = 0.387). In patients with neuromuscular onset rhythm disturbances occurred usually before evidence of cardiomyopathy. Despite these differences, the need for heart transplantation and median age at intervention were similar in the two groups (29% vs 23% [p = 0.717] and 43 vs 46 years [p = 0.593] respectively).

Conclusions

In patients with laminopathy, the type of disease onset was a marker for a different natural history. Specifically, patients with neuromuscular presentation had an earlier cardiac involvement, characterized by a linear and progressive evolution from rhythm disorders (AF and/or A-V block) to cardiomyopathy.
Literature
1.
go back to reference Mounkes L, Kozlov S, Burke B, Stewart CL. The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev. 2003;13:223–30.CrossRef Mounkes L, Kozlov S, Burke B, Stewart CL. The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev. 2003;13:223–30.CrossRef
2.
go back to reference Shackleton S, et al. LMNA, encoding Lamin a/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153–6.CrossRef Shackleton S, et al. LMNA, encoding Lamin a/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153–6.CrossRef
3.
go back to reference Boriani G, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke. 2003;34:901–8.CrossRef Boriani G, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke. 2003;34:901–8.CrossRef
4.
go back to reference Eriksson M, et al. Recurrent de novo point mutations in Lamin a cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293–8.CrossRef Eriksson M, et al. Recurrent de novo point mutations in Lamin a cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293–8.CrossRef
5.
go back to reference Bonne G, et al. Mutations in the gene encoding Lamin a/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21:285–8.CrossRef Bonne G, et al. Mutations in the gene encoding Lamin a/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21:285–8.CrossRef
6.
go back to reference Arbustini E, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a Lamin a/C defect-related disease. J Am Coll Cardiol. 2002;39:981–90.CrossRef Arbustini E, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a Lamin a/C defect-related disease. J Am Coll Cardiol. 2002;39:981–90.CrossRef
7.
go back to reference Kumar S, et al. Long-term arrhythmic and nonarrhythmic outcomes of Lamin a/C mutation carriers. J Am Coll Cardiol. 2016;68:2299–307.CrossRef Kumar S, et al. Long-term arrhythmic and nonarrhythmic outcomes of Lamin a/C mutation carriers. J Am Coll Cardiol. 2016;68:2299–307.CrossRef
8.
go back to reference Pasotti M, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250–60.CrossRef Pasotti M, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250–60.CrossRef
9.
go back to reference Taylor MR, et al. Natural history of dilated cardiomyopathy due to Lamin a/C gene mutations. J Am Coll Cardiol. 2003;41:771–80.CrossRef Taylor MR, et al. Natural history of dilated cardiomyopathy due to Lamin a/C gene mutations. J Am Coll Cardiol. 2003;41:771–80.CrossRef
10.
go back to reference van Rijsingen IA, et al. Risk factors for malignant ventricular arrhythmias in Lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59:493–500.CrossRef van Rijsingen IA, et al. Risk factors for malignant ventricular arrhythmias in Lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59:493–500.CrossRef
11.
go back to reference Hasselberg NE, et al. Lamin a/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853–60.CrossRef Hasselberg NE, et al. Lamin a/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853–60.CrossRef
12.
13.
go back to reference Wahbi K, et al. Development and validation of a new risk prediction score for life-threatening ventricular Tachyarrhythmias in Laminopathies. Circulation. 2019;140:293–302.CrossRef Wahbi K, et al. Development and validation of a new risk prediction score for life-threatening ventricular Tachyarrhythmias in Laminopathies. Circulation. 2019;140:293–302.CrossRef
14.
go back to reference Elliott P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.CrossRef Elliott P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.CrossRef
15.
go back to reference Pinto YM, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8.CrossRef Pinto YM, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8.CrossRef
16.
go back to reference Benedetti S, et al. Phenotypic clustering of Lamin a/C mutations in neuromuscular patients. Neurology. 2007;69:1285–92.CrossRef Benedetti S, et al. Phenotypic clustering of Lamin a/C mutations in neuromuscular patients. Neurology. 2007;69:1285–92.CrossRef
17.
go back to reference Bonne G, et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the Lamin a/C gene. Ann Neurol. 2000;48:170–80.CrossRef Bonne G, et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the Lamin a/C gene. Ann Neurol. 2000;48:170–80.CrossRef
18.
go back to reference Brodsky GL, et al. Lamin a/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000;101:473–6.CrossRef Brodsky GL, et al. Lamin a/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000;101:473–6.CrossRef
19.
go back to reference Quarta G, et al. Mutations in the Lamin a/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2012;33:1128–36.CrossRef Quarta G, et al. Mutations in the Lamin a/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2012;33:1128–36.CrossRef
Metadata
Title
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset
Authors
Raffaello Ditaranto
Giuseppe Boriani
Mauro Biffi
Massimiliano Lorenzini
Maddalena Graziosi
Matteo Ziacchi
Ferdinando Pasquale
Giovanni Vitale
Alessandra Berardini
Rita Rinaldi
Giovanna Lattanzi
Luciano Potena
Sofia Martin Suarez
Maria Letizia Bacchi Reggiani
Claudio Rapezzi
Elena Biagini
Publication date
01-12-2019

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue